Literature DB >> 12865396

Analysis of dual active fluoroquinolones in Streptococcus pneumoniae.

L Mark Fisher, Katherine A Gould, Xiao-Su Pan, Sandhiya Patel, Victoria J Heaton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12865396     DOI： 10.1093/jac/dkg329

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases.

Authors:  Michael T Black; Thérèse Stachyra; Denis Platel; Anne-Marie Girard; Monique Claudon; Jean-Michel Bruneau; Christine Miossec
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

2.  Genomic characterization of ciprofloxacin resistance in a laboratory-derived mutant and a clinical isolate of Streptococcus pneumoniae.

Authors:  Andréanne Lupien; Dewan S Billal; Fereshteh Fani; Hafid Soualhine; George G Zhanel; Philippe Leprohon; Marc Ouellette
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

3.  Ciprofloxacin dimers target gyrase in Streptococcus pneumoniae.

Authors:  Katherine A Gould; Xiao-Su Pan; Robert J Kerns; L Mark Fisher
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

4.  Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections.

Authors:  F Wagenlehner; M Nowicki; C Bentley; M Lückermann; S Wohlert; C Fischer; A Vente; K Naber; A Dalhoff
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.